BioClinica releases Express EDC solution for clinical trials

BioClinica®, Inc. (NASDAQ: BIOC), a global provider of clinical trial management solutions, announced the latest release of BioClinica Express EDC. This modern, web-based platform is a comprehensive electronic data capture (EDC) solution that adds speed and quality to every part of the clinical trial process. Enhanced to utilize the latest web technologies, Express EDC makes it easier to monitor protocol compliance and close studies faster while meeting necessary regulations and guidelines. The newest Express application improves on the usability that sites already consider 'easiest' with flexible, scalable technology that coordinates and organizes the collection and dissemination of clean data.

Express joins BioClinica's other solutions to improve the efficiency and flexibility required for modern clinical trials. Express is fully integrated in real-time with BioClinca's Trident IWR and OnPoint CTMS systems. This enables real time data exchange between Express and OnPoint CTMS to support site payment data or visit status updates. Complementing best-in-class functionality is a web services architecture that communicates in real-time between applications and maximizes data visibility and utility via SharePoint with built-in connectivity to Outlook and other Microsoft Office applications. Express also provides on-demand exports for further analysis in SAS or other analytical tools.

"This release of Express EDC is a major advancement for the BioClinica Suite. Sponsors and CROs can choose any of our world-class solutions as a stand-alone or a starting point - then augment functionality for any study when they need it," said Peter Benton, President of eClinical Solutions for BioClinica. "With the only portfolio of eClinical applications all created within the last five years, BioClinica offers a remarkably different approach with fresh ideas to address the challenges facing clinical organizations globally."

BioClinica Express provides new capabilities for EDC power users that make slicing and dicing incoming data fast and easy and automatically encodes medical terms within the same application. Role-specific dashboards focus attention where it's needed the most and data managers can tag or bookmark data to facilitate workflow, save customized data and query listings as 'private' or 'public' for later use. Study build timelines are minimized using an innovative design environment that reduces programming and maximizes re-usability.

Express delivers CDISC-compliant output at the end of the trial to save sponsors time and maximize exchange or integration with partners. Express can also incorporate external data such as labs, PK data, imaging metadata, and other instrumentation data with the clinical data during the trial. This process eliminates end-of-study reconciliation, provides cleaner data faster, and simplifies the submission process.

Source: BioClinica

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Clario. (2011, September 12). BioClinica releases Express EDC solution for clinical trials. News-Medical. Retrieved on November 24, 2024 from https://www.news-medical.net/news/20110912/BioClinica-releases-Express-EDC-solution-for-clinical-trials.aspx.

  • MLA

    Clario. "BioClinica releases Express EDC solution for clinical trials". News-Medical. 24 November 2024. <https://www.news-medical.net/news/20110912/BioClinica-releases-Express-EDC-solution-for-clinical-trials.aspx>.

  • Chicago

    Clario. "BioClinica releases Express EDC solution for clinical trials". News-Medical. https://www.news-medical.net/news/20110912/BioClinica-releases-Express-EDC-solution-for-clinical-trials.aspx. (accessed November 24, 2024).

  • Harvard

    Clario. 2011. BioClinica releases Express EDC solution for clinical trials. News-Medical, viewed 24 November 2024, https://www.news-medical.net/news/20110912/BioClinica-releases-Express-EDC-solution-for-clinical-trials.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
BioClinica third quarter service revenues increase 4.1% to $16.6 million